Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
A financial planner can help you navigate retirement planning, ensuring you have the right strategies in place for a secure future.
25,466 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Microsoft is doubling down on AI. This article lays out scenarios, risks, and concrete steps to understand where will...
Markets showed modest gains as the Fed meeting kicked off, with tech and travel shares helping lift indexes. This gui...
A SpaceX IPO could reshape tech investing, but it won’t happen in a vacuum. This guide explains why Amazon’s space an...
AI-driven power demand is reshaping the clean-energy landscape, and Bloom Energy is at the center of the move. This g...
A major enterprise contract could transform D-Wave from a hardware play into a recurring-revenue champion. This artic...
A biotech stock that surged 700% remains a cornerstone of many portfolios even after a sizable last-quarter sale by a...
A veteran MIT roboticist who cofounded bankrupt robot iRobot cautions that Elon Musk's humanoid vision is not close t...
Tariff headlines and policy shifts are shaking crypto markets. This piece unpacks the sell-off, shows where prices mo...
Buying nebius group stock represents a high-conviction AI infrastructure play. This guide breaks down the business, m...
Quantum stocks have been front and center as grants and hype push prices higher. This guide explains why infleqtion s...
Ready for a portfolio that ages well with time? This guide zeroes in on three monster stocks hold next—MercadoLibre, ...